Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2017-10-18
2019-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition, the secondary objective is to determine the effect of essential amino acids on satellite cell regulation and inflammatory responses during this prolonged recovery period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Amino Acids to Enhance Anabolism After Home-based Exercise
NCT04850820
The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients
NCT01211717
Effect of Supplementing a Mixed Macronutrient Beverage With Graded Doses of Leucine on Myofibrillar Protein Synthesis
NCT01885429
Modulation of Muscle Protein Metabolism by Essential Amino Acids
NCT01890369
Branched-chain Amino Acids Supplementation and Resistance Exercise-induced Muscle Damage and Inflammation
NCT01305018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
4g of maltodextrin
Placebo
4g of maltdextrin
Active
4g of essential amino acids
Active
4g of essential amino acids
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active
4g of essential amino acids
Placebo
4g of maltdextrin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone; Appendix. B). Active will be defined as being in the top 20% of age specific scores on iPAQ (the International Physical Activity Questionnaire; Appendix.C).
* Participants are required not to engage in lower limb RT (resistance training) for at least 6 months prior to the study.
* Participants will be 18-35 years old.
* Participants are willing to abide by the compliance rules of this study
Exclusion Criteria
* Inability to adhere to any of the compliance rules judged by principle investigator or medical doctor
* Self-reported regular tobacco use
* Self-reported illicit drug use (e.g. growth hormone, testosterone, etc.)
* The individual who has allergy for milk
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajinomoto Co., Inc.
INDUSTRY
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Moore
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Goldring Centre for High Performance Sport
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EAA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.